In this connection, the present study was designed to evaluate the effectivity of the compounds against those enzymes the inhibition of which could help in T2DM (alpha-amylase and alpha-glucosidase) and AD (cholinesterases), on one hand, and to have free radical scavenging activity, on the other. This evidence concerns the gene GAA and type 2 diabetes mellitus.